EDIT:NASDAQ
Editas Medicine Inc
2,17 US$
arrow_upward
+1,40%(+0,030) 1D
13 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,14 US$
High
2,21 US$
Low
2,01 US$
Mkt. cap
334,92 მლნ.
Avg. vol.
2,42 მლნ.
Volume
2,79 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
2,14 US$
High
2,21 US$
Low
2,01 US$
Mkt. cap
334,92 მლნ.
Avg. vol.
2,42 მლნ.
Volume
2,79 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
BigGo Finance
·
27 წუთის წინ
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
FOREX.com
·
11 წუთის წინ
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
TheStreet
·
55 წუთის წინ
Goldman Sachs reset S&P 500 price target for 2027
Traders Union
·
3 საათის წინ
Quinten Francois: Bitcoin and Ethereum underperform S&P 500 over five years
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc